Remove Journal Remove Pricing Remove Technical Review
article thumbnail

How Do I Feel About the Snap IPO Given I Didn’t Invest?

Both Sides of the Table

Every tech or major news journal in the country is preparing to write their Snap, Inc (creators of Snapchat, Spectacles, etc) stories and many of them seem to want a “How does it feel to have missed this investment story.” I hear tons of ideas for early-stage apps. Another firm funded them. That’s a benefit for us as a local VC.

Snapchat 214
article thumbnail

Bio Roundup: Theranos Cuts, Alnylam Stops, Nobel Eats Its Own & More

Xconomy

military’s high-tech think tank DARPA described Safe Genes, a new program to fund safety measures that can be built into genome editing technology or counter its potential wayward effects. —The 2016 Nobel Prize for Physiology or Medicine went to Yoshinori Ohsumi of the Tokyo Institute of Technology. PRICE FIGHTS.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Bio Roundup: FDA Says No, PCSK9 Value Fight, CRISPR Intrigue & More

Xconomy

The CRISPR news this week doesn’t need a metaphor; the drama that MIT Technology Review reported can stand alone. — MIT Technology Review reported this week that a graduate student in the lab of Feng Zhang, Broad Institute gene-editing star, had accused the Broad of misleading the U.S. .

article thumbnail

Bio Roundup: RIP Roger Tsien, Novartis CAR-T Wheel, Zika News & More

Xconomy

Just last month, a startup Tsien cofounded announced a round of funding to push ahead with a fluorescent technology that aims to help surgeons cut out tumors without removing healthy tissue. For more on Tsien and the rest of the week’s news, let’s get to the roundup.

News 57
article thumbnail

Bio Roundup: Precision Med and Google, Heron, Lilly, Sarepta & More

Xconomy

government’s Precision Medicine Initiative is an ambitious effort to collect the genomic data of 1 million Americans, and tech giant Alphabet (NASDAQ: GOOG ) is deeply involved. That story and the rest of the week’s biotech headlines below. —The U.S. —David H. In the U.S.,

Google 40
article thumbnail

Interview: Ian Siegel of ZipRecruiter

InfoChachkie

Messenger : Ian Siegel , Co-Founder |CEO ZipRecruiter , Former Executive Product and Technology roles at: MyLife, CitySearch, Stamps.com, Rent.com and Pictage. I think the biggest problem Monster, HotJobs, and CareerBuilder face right now is that they are charging premium prices for what is an increasingly commoditized product.

MyLife 160
article thumbnail

Interview: Ian Siegel of ZipRecruiter

InfoChachkie

Messenger : Ian Siegel , Co-Founder |CEO ZipRecruiter , Former Executive Product and Technology roles at: MyLife, CitySearch, Stamps.com, Rent.com and Pictage. I think the biggest problem Monster, HotJobs, and CareerBuilder face right now is that they are charging premium prices for what is an increasingly commoditized product.

MyLife 157